These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 22865455)
21. Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations. Yang Z; Zhang L; Ma A; Liu L; Li J; Gu J; Liu Y PLoS One; 2011; 6(12):e28405. PubMed ID: 22145042 [TBL] [Abstract][Full Text] [Related]
22. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor. Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034 [TBL] [Abstract][Full Text] [Related]
23. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294 [TBL] [Abstract][Full Text] [Related]
24. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks. Tabu K; Kimura T; Sasai K; Wang L; Bizen N; Nishihara H; Taga T; Tanaka S Mol Cancer; 2010 Feb; 9():39. PubMed ID: 20167130 [TBL] [Abstract][Full Text] [Related]
25. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372 [TBL] [Abstract][Full Text] [Related]
26. Reversing effect of Lupeol on vasculogenic mimicry in murine melanoma progression. Bhattacharyya S; Mitra D; Ray S; Biswas N; Banerjee S; Majumder B; Mustafi SM; Murmu N Microvasc Res; 2019 Jan; 121():52-62. PubMed ID: 30381268 [TBL] [Abstract][Full Text] [Related]
27. In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemoresistant CD133+ tumor-initiating cell subset. Kucerova L; Feketeova L; Kozovska Z; Poturnajova M; Matuskova M; Nencka R; Babal P Thyroid; 2014 Mar; 24(3):520-32. PubMed ID: 24073856 [TBL] [Abstract][Full Text] [Related]
28. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics. Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735 [TBL] [Abstract][Full Text] [Related]
29. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635 [TBL] [Abstract][Full Text] [Related]
30. CD133⁺ melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: significance for melanoma treatment. El-Khattouti A; Sheehan NT; Monico J; Drummond HA; Haikel Y; Brodell RT; Megahed M; Hassan M Cancer Lett; 2015 Feb; 357(1):83-104. PubMed ID: 25449786 [TBL] [Abstract][Full Text] [Related]
31. All-trans retinoic acid impairs the vasculogenic mimicry formation ability of U87 stem-like cells through promoting differentiation. Ling GQ; Liu YJ; Ke YQ; Chen L; Jiang XD; Jiang CL; Ye W Mol Med Rep; 2015 Jul; 12(1):165-72. PubMed ID: 25760394 [TBL] [Abstract][Full Text] [Related]
32. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells. Leng Z; Tao K; Xia Q; Tan J; Yue Z; Chen J; Xi H; Li J; Zheng H PLoS One; 2013; 8(2):e56082. PubMed ID: 23418515 [TBL] [Abstract][Full Text] [Related]
33. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma. Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537 [TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer. Nakamura M; Zhang X; Mizumoto Y; Maida Y; Bono Y; Takakura M; Kyo S Int J Oncol; 2014 Mar; 44(3):669-77. PubMed ID: 24366104 [TBL] [Abstract][Full Text] [Related]
35. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer. Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309 [TBL] [Abstract][Full Text] [Related]
36. Cancer stem cells: lessons from melanoma. La Porta C Stem Cell Rev Rep; 2009 Mar; 5(1):61-5. PubMed ID: 19093230 [TBL] [Abstract][Full Text] [Related]
37. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy. Kubo T; Takigawa N; Osawa M; Harada D; Ninomiya T; Ochi N; Ichihara E; Yamane H; Tanimoto M; Kiura K Cancer Sci; 2013 Jan; 104(1):78-84. PubMed ID: 23066953 [TBL] [Abstract][Full Text] [Related]
38. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer. Liu TJ; Sun BC; Zhao XL; Zhao XM; Sun T; Gu Q; Yao Z; Dong XY; Zhao N; Liu N Oncogene; 2013 Jan; 32(5):544-53. PubMed ID: 22469978 [TBL] [Abstract][Full Text] [Related]
39. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma. Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968 [TBL] [Abstract][Full Text] [Related]
40. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? Wei C; Guomin W; Yujun L; Ruizhe Q Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]